About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Active Not RecruitingNCT03366545

Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices

The registry is primarily designed to assess outcome, efficacy and residual safety aspects of CRT based on long-term data from an unselected, real-life clinical set-up. Moreover, the observation of th...

Lead sponsor: Biotronik SE & Co. KG•114 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Biotronik SE & Co. KG

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Planned de novo implantation of or upgrade to a CRT system for treatment according to the intended use
•Patient is able to understand the nature of the registry and has provided written informed consent
•Patient is willing and able to use the CardioMessenger and accepts the Home Monitoring concept
•Remote monitoring using the Home Monitoring® platform is planned for the patient

Exclusion Criteria

•Standard contraindication for CRT
•Already or previously implanted with CRT system
•• Age \< 18 years
•Participation in another interventional clinical investigation other than the registry-based trials of BIO\|STREAM.HF
•Pregnant or breastfeeding

Related studies

MRI Assessment of Pulmonary Edema in Acute Heart Failure

NCT03999138 · Acute Heart Failure, Pulmonary Edema With Heart Failure

Biomarker Guided Discharge of Heart Failure Patients

NCT03103932 · Heart Failure; With Decompensation

RECRUITINGPhase 2

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

NCT06762964 · Fontan Circulation, Single Ventricle Heart Disease, and more

Assessing Systemic Circulation and LV Performance in Adults

NCT04347655 · Heart Failure

RECRUITINGPhase 2

A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

NCT07083011 · Heart Failure With Preserved Ejection Fraction

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 12, 2026Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment3,030

Start dateMay 2018

Last updatedFeb 12, 2026

Condition

Locations shown

Canberra Heart Rhythm Foundation

Canberra

The Canberra Hospital

Canberra

Lyell McEwin Hospital

Elizabeth Vale

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 12, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions